We've found
						33,560
						 archived clinical trials in
						Neurology
					
				We've found
						33,560
						 archived clinical trials in
						Neurology
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
	
	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
	
Updated: 10/27/2016
  
  
  	  A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
		Status: Enrolling	
	Updated: 10/27/2016
Click here to add this to my saved trials
		    
			
	Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study
	
Updated: 11/1/2016
  
  
  Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study
		Status: Enrolling	
	Updated: 11/1/2016
	
	Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study
	
Updated: 11/1/2016
  
  
  	  Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study
		Status: Enrolling	
	Updated: 11/1/2016
Click here to add this to my saved trials
		    
			
	Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
	
Updated: 11/14/2016
  
  
  The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
		Status: Enrolling	
	Updated: 11/14/2016
	
	Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
	
Updated: 11/14/2016
  
  
  	  The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
		Status: Enrolling	
	Updated: 11/14/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
	
	Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
	
Updated: 11/21/2016
  
  
  	  A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
		Status: Enrolling	
	Updated: 11/21/2016
Click here to add this to my saved trials
		    
			
	Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
	
Updated: 11/22/2016
  
  
  Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
		Status: Enrolling	
	Updated: 11/22/2016
	
	Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
	
Updated: 11/22/2016
  
  
  	  Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
		Status: Enrolling	
	Updated: 11/22/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials
		    
			
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
	
	Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
	
Updated: 11/29/2016
  
  
  	  Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups
		Status: Enrolling	
	Updated: 11/29/2016
Click here to add this to my saved trials